AI endoscopic image analysis software, developed through years of joint research with Professor Kim Ji-hyun's research team, a gastroenterologist at Gangnam Severance Hospital...Received industry's First Innovation Award in Health/Wellness at CES 2022
AI endoscopic image analysis software "WAYMED Endo," developed by Waycen (CEO Kim Kyung-nam), an artificial intelligence (AI) Meditech company, won the Health/Wellness Innovation Award at CES 2022 for the first time in the industry.
This is the first time that AI endoscopic image analysis software has been selected at the CES Innovation Award. Waycen achieved the feat of winning the award, which has not been received by global medical companies, three years after its establishment.
WAYMEDendo is an endoscopic image analysis software based on artificial intelligence. While performing endoscopy in the endoscopy room, artificial intelligence detects abnormal areas (rise or depression) in real time, and medical staff can immediately check the abnormal areas at the endoscopy room site.
Users received the award in recognition of their innovation in that they can detect abnormalities in digestive health early thanks to WAYMED Endo noticing abnormal areas.
In addition, WAYMED Endo can be provided even in the cloud and standalone, so it can be used in medical developing countries.
This can reduce the health care gap due to medical technology deviations, and it was highly praised for contributing to the international medical development by early detection and treatment of abnormalities in the stomach/colorectal of more people through medical AI technology.
Waycen CEO Kim Kyung-nam said, "WAYMED ENDO is a product that has been developed for global market from the planning stage. "I think this award is a very positive sign of the global advancement of AI endoscopic image analysis SW 'WAYMED endo', and I will do my best to become a product that is recognized not only in Korea but also abroad," he said.
Meanwhile, WAYMED Endo is a product developed through years of joint research with Professor Kim Ji-hyun's research team, a gastroenterologist at Gangnam Severance Hospital. It has significant meaning in the medical industry that medical experts and artificial intelligence companies collaborated to develop clinically useful products along with technical verification and achieved such excellent results.
AI endoscopic image analysis software, developed through years of joint research with Professor Kim Ji-hyun's research team, a gastroenterologist at Gangnam Severance Hospital...Received industry's First Innovation Award in Health/Wellness at CES 2022
AI endoscopic image analysis software "WAYMED Endo," developed by Waycen (CEO Kim Kyung-nam), an artificial intelligence (AI) Meditech company, won the Health/Wellness Innovation Award at CES 2022 for the first time in the industry.
This is the first time that AI endoscopic image analysis software has been selected at the CES Innovation Award. Waycen achieved the feat of winning the award, which has not been received by global medical companies, three years after its establishment.
WAYMEDendo is an endoscopic image analysis software based on artificial intelligence. While performing endoscopy in the endoscopy room, artificial intelligence detects abnormal areas (rise or depression) in real time, and medical staff can immediately check the abnormal areas at the endoscopy room site.
Users received the award in recognition of their innovation in that they can detect abnormalities in digestive health early thanks to WAYMED Endo noticing abnormal areas.
In addition, WAYMED Endo can be provided even in the cloud and standalone, so it can be used in medical developing countries.
This can reduce the health care gap due to medical technology deviations, and it was highly praised for contributing to the international medical development by early detection and treatment of abnormalities in the stomach/colorectal of more people through medical AI technology.
Waycen CEO Kim Kyung-nam said, "WAYMED ENDO is a product that has been developed for global market from the planning stage. "I think this award is a very positive sign of the global advancement of AI endoscopic image analysis SW 'WAYMED endo', and I will do my best to become a product that is recognized not only in Korea but also abroad," he said.
Meanwhile, WAYMED Endo is a product developed through years of joint research with Professor Kim Ji-hyun's research team, a gastroenterologist at Gangnam Severance Hospital. It has significant meaning in the medical industry that medical experts and artificial intelligence companies collaborated to develop clinically useful products along with technical verification and achieved such excellent results.
Source : 인공지능신문(http://www.aitimes.kr)